D.E. Shaw & Co
INDV icon

D.E. Shaw & Co’s Indivior Pharmaceuticals INDV Stock Holding History

D.E. Shaw & Co’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.68M Buy
236,034
+32,049
+16% +$1.16M ﹤0.01% 1835
2026
Q1 		$6.22M Buy
203,985
+33,118
+19% +$1.09M ﹤0.01% 2017
2025
Q4 		$6.13M Sell
170,867
-42,387
-20% -$1.29M ﹤0.01% 2140
2025
Q3 		$5.14M Buy
213,254
+118,621
+125% +$2.48M ﹤0.01% 2183
2025
Q2 		$1.39M Buy
94,633
+26,529
+39% +$309K ﹤0.01% 3005
2025
Q1 		$649K Sell
68,104
-31,502
-32% -$331K ﹤0.01% 3348
2024
Q4 		$1.24M Buy
+99,606
New +$1.02M ﹤0.01% 3084

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co's INDV Position: Q2 2026 in Review

D.E. Shaw & Co increased its Indivior Pharmaceuticals (INDV) stake by 16% in Q2 2026, buying an estimated $1.16M and bringing the position to 236,034 shares worth $9.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1835.

D.E. Shaw & Co first reported a position in INDV in Q4 2024 and has held it in 7 quarters since. 339 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • D.E. Shaw & Co held 236,034 shares of Indivior Pharmaceuticals worth $9.68M as of Q2 2026.
  • D.E. Shaw & Co bought 32,049 Indivior Pharmaceuticals shares in Q2 2026, an estimated $1.16M.
  • Indivior Pharmaceuticals made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #1835 holding.
  • D.E. Shaw & Co first reported a position in Indivior Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 339 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.